The EPS projection of Dun & Bradstreet Corporation (The) (NYSE:DNB) for quarter ended 2016-09-30 is $1.82. Last week, the projection for EPS was $1.82 against target of $1.82, a month earlier. While 2-months ago, this projection was $1.82 versus forecast of $1.82a quarter months earlier, posting a deviation of 0%.
Dun & Bradstreet Corporation (The) (NYSE:DNB) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 4, and 3, correspondingly.
The per-share earnings downgrade for Dun & Bradstreet Corporation (The) (NYSE:DNB) in the preceding 30 and 120 were 1 and 1. While in 60 and 90 days were 1, and 1, in that order.
Dun & Bradstreet Corporation (The) (NYSE:DNB) EPS target was $1.82 for the quarter closed 1. It was based on 5 calls. As on 2016-05-09 the EPS was $1.18. The change was $0.24, posting a deviation of 25.53%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Dun & Bradstreet Corporation (The) (NYSE:DNB) sales prediction for the fiscal 2017 stands at $549.65 and the median estimate is at $549.65. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $554.8 while the lowest target is $544.5 showing standard deviation of 7.283%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -0.335%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...